[0.1% 环孢素 A 阳离子乳剂在治疗眼干症中的地位]。

Q3 Medicine Vestnik oftalmologii Pub Date : 2024-01-01 DOI:10.17116/oftalma2024140021102
D Yu Maychuk, E V Yani, V V Brzheskiy, E E Grishina, E A Drozdova, N V Maychuk, I E Panova, T N Safonova
{"title":"[0.1% 环孢素 A 阳离子乳剂在治疗眼干症中的地位]。","authors":"D Yu Maychuk, E V Yani, V V Brzheskiy, E E Grishina, E A Drozdova, N V Maychuk, I E Panova, T N Safonova","doi":"10.17116/oftalma2024140021102","DOIUrl":null,"url":null,"abstract":"<p><p>Dry eye disease (DED) is pathogenetically based on inflammation of the ocular surface. A step-by-step approach to DED treatment involves early initiation of anti-inflammatory therapy, including instillation of cyclosporine A (CsA). However, recommendations for the use of topical CsA in clinical practice are limited. This article presents an expert consensus on practical recommendations for the management of patients with DED, including indications, time of initiation and duration of CsA therapy, comparison of CsA forms currently registered in the Russian Federation, as well as issues of patient education.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 2","pages":"102-111"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The place of ciclosporin A cationic emulsion 0.1% in the therapy of xerophthalmia].\",\"authors\":\"D Yu Maychuk, E V Yani, V V Brzheskiy, E E Grishina, E A Drozdova, N V Maychuk, I E Panova, T N Safonova\",\"doi\":\"10.17116/oftalma2024140021102\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Dry eye disease (DED) is pathogenetically based on inflammation of the ocular surface. A step-by-step approach to DED treatment involves early initiation of anti-inflammatory therapy, including instillation of cyclosporine A (CsA). However, recommendations for the use of topical CsA in clinical practice are limited. This article presents an expert consensus on practical recommendations for the management of patients with DED, including indications, time of initiation and duration of CsA therapy, comparison of CsA forms currently registered in the Russian Federation, as well as issues of patient education.</p>\",\"PeriodicalId\":23529,\"journal\":{\"name\":\"Vestnik oftalmologii\",\"volume\":\"140 2\",\"pages\":\"102-111\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vestnik oftalmologii\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17116/oftalma2024140021102\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vestnik oftalmologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/oftalma2024140021102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

干眼症(DED)的病理基础是眼表发炎。DED 治疗的循序渐进方法包括尽早开始抗炎治疗,包括灌注环孢素 A (CsA)。然而,在临床实践中使用局部 CsA 的建议并不多。本文介绍了专家就 DED 患者管理的实用建议达成的共识,包括 CsA 治疗的适应症、开始时间和持续时间、目前在俄罗斯联邦注册的 CsA 形态比较以及患者教育问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[The place of ciclosporin A cationic emulsion 0.1% in the therapy of xerophthalmia].

Dry eye disease (DED) is pathogenetically based on inflammation of the ocular surface. A step-by-step approach to DED treatment involves early initiation of anti-inflammatory therapy, including instillation of cyclosporine A (CsA). However, recommendations for the use of topical CsA in clinical practice are limited. This article presents an expert consensus on practical recommendations for the management of patients with DED, including indications, time of initiation and duration of CsA therapy, comparison of CsA forms currently registered in the Russian Federation, as well as issues of patient education.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vestnik oftalmologii
Vestnik oftalmologii Medicine-Ophthalmology
CiteScore
0.80
自引率
0.00%
发文量
129
期刊介绍: The journal publishes materials on the diagnosis and treatment of eye diseases, hygiene of vision, prevention of ophthalmic affections, history of Russian ophthalmology, organization of ophthalmological aid to the population, as well as the problems of special equipment. Original scientific articles and surveys on urgent problems of theory and practice of Russian and foreign ophthalmology are published. The journal contains book reviews on ophthalmology, information on the activities of ophthalmologists" scientific societies, chronicle of congresses and conferences.The journal is intended for ophthalmologists and scientific workers dealing with clinical problems of diseases of the eye and physiology of vision.
期刊最新文献
[Structural and functional features of the eye in Marfan syndrome. Report 2. Changes in the anatomical complex of the lens]. [Subfamily of betaherpesviruses as a cause of epithelial and stromal keratitis]. [Terson syndrome and acute myeloid leukemia (case report)]. [The association between myopia and glaucoma]. [The effect of pleoptic treatment on the stability of visual fixation in children and adolescents with amblyopia of various degrees].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1